In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
The Liposome Company initiates clinical trial of Evacet
The Liposome Company and Bristol-Myers Squibb collaborate on combination therapy trials
The Liposome Company receives regulatory approval for Abelcet
Kissei files for Japanese approval
Elan to acquire The Liposome Company
CytoGenix and Endovasc begin cooperative research
Duke University grants Celsion exclusive liposome license
NeoPharm terminates license agreement with Pharmacia
Liposome's Evacet filing accepted in Europe: trial collaboration with RPR
Cantab exercises option to license Novavax liposome adjuvants